DE69109292T2 - Verminderung oder verhütung der von arzneimitteln verursachten hautreizung. - Google Patents
Verminderung oder verhütung der von arzneimitteln verursachten hautreizung.Info
- Publication number
- DE69109292T2 DE69109292T2 DE69109292T DE69109292T DE69109292T2 DE 69109292 T2 DE69109292 T2 DE 69109292T2 DE 69109292 T DE69109292 T DE 69109292T DE 69109292 T DE69109292 T DE 69109292T DE 69109292 T2 DE69109292 T2 DE 69109292T2
- Authority
- DE
- Germany
- Prior art keywords
- drug
- skin
- irritation
- prevention
- reduction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/549,584 US5130139A (en) | 1990-07-06 | 1990-07-06 | Reduction or prevention of skin irritation by drugs |
PCT/US1991/004685 WO1992000746A1 (en) | 1990-07-06 | 1991-07-01 | Reduction or prevention of skin irritation by drugs |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69109292D1 DE69109292D1 (de) | 1995-06-01 |
DE69109292T2 true DE69109292T2 (de) | 1995-08-31 |
Family
ID=24193593
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69109292T Expired - Fee Related DE69109292T2 (de) | 1990-07-06 | 1991-07-01 | Verminderung oder verhütung der von arzneimitteln verursachten hautreizung. |
Country Status (18)
Country | Link |
---|---|
US (1) | US5130139A (de) |
EP (1) | EP0538302B1 (de) |
JP (1) | JP3224814B2 (de) |
AT (1) | ATE121627T1 (de) |
AU (1) | AU641787B2 (de) |
CA (1) | CA2046014C (de) |
DE (1) | DE69109292T2 (de) |
DK (1) | DK0538302T3 (de) |
ES (1) | ES2071322T3 (de) |
FI (1) | FI930038A (de) |
GR (1) | GR3015934T3 (de) |
IE (1) | IE74152B1 (de) |
MX (1) | MX9100042A (de) |
NO (1) | NO925038L (de) |
NZ (1) | NZ238804A (de) |
PT (1) | PT98177B (de) |
WO (1) | WO1992000746A1 (de) |
ZA (1) | ZA915067B (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100228004B1 (ko) * | 1991-11-08 | 1999-11-01 | 가마쿠라 아키오 | 살균성 점착제(粘着制)와 그 제조방법 및 점착제품과 그 응용 |
US5843979A (en) * | 1993-02-25 | 1998-12-01 | Bristol-Myers Squibb Company | Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity |
IL109036A (en) * | 1993-03-19 | 1998-12-27 | Cellegy Pharamaceuticals Inc | Preparations for detachment of the epithelial barrier function and use of means for the preparation of such preparations |
US6190894B1 (en) | 1993-03-19 | 2001-02-20 | The Regents Of The University Of California | Method and compositions for disrupting the epithelial barrier function |
US5451407A (en) * | 1993-06-21 | 1995-09-19 | Alza Corporation | Reduction or prevention of skin irritation or sensitization during transdermal administration of a irritating or sensitizing drug |
DE69502281T2 (de) * | 1994-03-30 | 1998-11-12 | Alza Corp | Verminderung der hautreizung während einer iontophoretischen abgabe von medikamenten |
WO1995034262A1 (en) * | 1994-06-16 | 1995-12-21 | Department Of The Army, Us Government | Transdermal treatment of malaria |
US5686100A (en) * | 1994-11-22 | 1997-11-11 | E.R. Squibb & Sons, Inc. | Prophylactic and therapeutic treatment of skin sensitization and irritation |
WO1997047355A1 (en) * | 1996-06-12 | 1997-12-18 | Alza Corporation | Reduction of skin sensitization in electrotransport drug delivery |
US6512010B1 (en) * | 1996-07-15 | 2003-01-28 | Alza Corporation | Formulations for the administration of fluoxetine |
US5981168A (en) * | 1998-05-15 | 1999-11-09 | The University Of British Columbia | Method and composition for modulating amyloidosis |
US6699497B1 (en) * | 1998-07-24 | 2004-03-02 | Alza Corporation | Formulations for the transdermal administration of fenoldopam |
US20040258742A1 (en) * | 2003-04-11 | 2004-12-23 | Van Osdol William Woodson | Transdermal administration of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methyl guanidines |
US7780981B2 (en) | 2004-09-13 | 2010-08-24 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery |
US8252321B2 (en) | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
US20070042026A1 (en) * | 2005-03-17 | 2007-02-22 | Wille John J | Prophylactic and therapeutic treatment of topical and transdermal drug-induced skin reactions |
WO2006127905A2 (en) | 2005-05-24 | 2006-11-30 | Chrono Therapeutics, Inc. | Portable drug delivery device |
JP2010516556A (ja) | 2007-01-25 | 2010-05-20 | 本田技研工業株式会社 | 車両の安定性を改善するための車両システムの制御方法 |
WO2013006643A1 (en) | 2011-07-06 | 2013-01-10 | The Parkinson's Institute | Compositions and methods for treatment of symptoms in parkinson's disease patients |
US10105487B2 (en) | 2013-01-24 | 2018-10-23 | Chrono Therapeutics Inc. | Optimized bio-synchronous bioactive agent delivery system |
MX359921B (es) * | 2013-02-08 | 2018-10-16 | Luoda Pharma Pty Ltd | Métodos de tratamiento tópico para infecciones microbianas. |
US10213586B2 (en) | 2015-01-28 | 2019-02-26 | Chrono Therapeutics Inc. | Drug delivery methods and systems |
AU2016228779A1 (en) | 2015-03-12 | 2017-09-07 | Chrono Therapeutics Inc. | Craving input and support system |
JP2020503950A (ja) | 2017-01-06 | 2020-02-06 | クロノ セラピューティクス インコーポレイテッドChrono Therapeutics Inc. | 経皮薬剤送達の装置及び方法 |
CA3101966A1 (en) | 2018-05-29 | 2019-12-05 | Morningside Venture Investments Limited | Drug delivery methods and systems |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3598123A (en) * | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
US3598122A (en) * | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
US3991755A (en) * | 1973-07-27 | 1976-11-16 | Medicon, Inc. | Iontophoresis apparatus for applying local anesthetics |
US4274420A (en) * | 1975-11-25 | 1981-06-23 | Lectec Corporation | Monitoring and stimulation electrode |
US4141359A (en) * | 1976-08-16 | 1979-02-27 | University Of Utah | Epidermal iontophoresis device |
US4325367A (en) * | 1977-06-13 | 1982-04-20 | Robert Tapper | Iontophoretic treatment apparatus |
US4250878A (en) * | 1978-11-22 | 1981-02-17 | Motion Control, Inc. | Non-invasive chemical species delivery apparatus and method |
CA1153427A (en) * | 1978-12-11 | 1983-09-06 | Patrick T. Cahalan | Tape electrode |
JPS56501274A (de) * | 1979-10-10 | 1981-09-10 | ||
US4286592A (en) * | 1980-02-04 | 1981-09-01 | Alza Corporation | Therapeutic system for administering drugs to the skin |
US4314557A (en) * | 1980-05-19 | 1982-02-09 | Alza Corporation | Dissolution controlled active agent dispenser |
US4379454A (en) * | 1981-02-17 | 1983-04-12 | Alza Corporation | Dosage for coadministering drug and percutaneous absorption enhancer |
JPS5810066A (ja) * | 1981-07-10 | 1983-01-20 | 株式会社アドバンス | イオントフオレ−ゼ用プラスタ−構造体 |
US4419092A (en) * | 1981-11-06 | 1983-12-06 | Motion Control, Inc. | Iontophoretic electrode structure |
GB2124485B (en) * | 1982-08-04 | 1986-06-04 | Michael A Levy | Penetrating topical medicament |
US4559222A (en) * | 1983-05-04 | 1985-12-17 | Alza Corporation | Matrix composition for transdermal therapeutic system |
US4557723A (en) * | 1983-08-18 | 1985-12-10 | Drug Delivery Systems Inc. | Applicator for the non-invasive transcutaneous delivery of medicament |
US4640689A (en) * | 1983-08-18 | 1987-02-03 | Drug Delivery Systems Inc. | Transdermal drug applicator and electrodes therefor |
US4708716A (en) * | 1983-08-18 | 1987-11-24 | Drug Delivery Systems Inc. | Transdermal drug applicator |
US4573995A (en) * | 1984-10-09 | 1986-03-04 | Alza Corporation | Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine |
US4702732A (en) * | 1984-12-24 | 1987-10-27 | Trustees Of Boston University | Electrodes, electrode assemblies, methods, and systems for tissue stimulation and transdermal delivery of pharmacologically active ligands |
FR2605221B1 (fr) * | 1986-10-20 | 1989-09-01 | Sanofi Sa | Compositions pharmaceutiques ou veterinaires contenant de la de(hydroxymethyl)-25 deoxy-25 oxo-25 monensine |
AU610839B2 (en) * | 1986-11-07 | 1991-05-30 | Purepac, Inc | Transdermal administration of amines |
US4983395A (en) * | 1987-11-12 | 1991-01-08 | Theratech Inc. | Device for administering an active agent to the skin or mucosa |
US4885154A (en) * | 1988-03-01 | 1989-12-05 | Alza Corporation | Method for reducing sensitization or irritation in transdermal drug delivery and means therefor |
US4855294A (en) * | 1988-09-06 | 1989-08-08 | Theratech, Inc. | Method for reducing skin irritation associated with drug/penetration enhancer compositions |
US4908213A (en) * | 1989-02-21 | 1990-03-13 | Schering Corporation | Transdermal delivery of nicotine |
EP0409406B1 (de) * | 1989-06-19 | 1993-09-08 | The Wellcome Foundation Limited | Arylsubstituierte Aminderivate verwendbar in der Krebstherapie |
-
1990
- 1990-07-06 US US07/549,584 patent/US5130139A/en not_active Expired - Lifetime
-
1991
- 1991-06-28 CA CA002046014A patent/CA2046014C/en not_active Expired - Fee Related
- 1991-07-01 ES ES91912369T patent/ES2071322T3/es not_active Expired - Lifetime
- 1991-07-01 PT PT98177A patent/PT98177B/pt not_active IP Right Cessation
- 1991-07-01 JP JP51195691A patent/JP3224814B2/ja not_active Expired - Fee Related
- 1991-07-01 AT AT91912369T patent/ATE121627T1/de not_active IP Right Cessation
- 1991-07-01 IE IE229491A patent/IE74152B1/en not_active IP Right Cessation
- 1991-07-01 EP EP91912369A patent/EP0538302B1/de not_active Expired - Lifetime
- 1991-07-01 NZ NZ238804A patent/NZ238804A/en unknown
- 1991-07-01 AU AU81046/91A patent/AU641787B2/en not_active Ceased
- 1991-07-01 MX MX9100042A patent/MX9100042A/es not_active IP Right Cessation
- 1991-07-01 WO PCT/US1991/004685 patent/WO1992000746A1/en active IP Right Grant
- 1991-07-01 ZA ZA915067A patent/ZA915067B/xx unknown
- 1991-07-01 DK DK91912369.5T patent/DK0538302T3/da active
- 1991-07-01 DE DE69109292T patent/DE69109292T2/de not_active Expired - Fee Related
-
1992
- 1992-12-30 NO NO92925038A patent/NO925038L/no unknown
-
1993
- 1993-01-05 FI FI930038A patent/FI930038A/fi not_active Application Discontinuation
-
1995
- 1995-04-27 GR GR940403851T patent/GR3015934T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA2046014A1 (en) | 1992-01-07 |
EP0538302A1 (de) | 1993-04-28 |
ZA915067B (en) | 1992-04-29 |
AU8104691A (en) | 1992-02-04 |
DE69109292D1 (de) | 1995-06-01 |
FI930038A0 (fi) | 1993-01-05 |
US5130139A (en) | 1992-07-14 |
WO1992000746A1 (en) | 1992-01-23 |
MX9100042A (es) | 1992-02-28 |
GR3015934T3 (en) | 1995-07-31 |
ES2071322T3 (es) | 1995-06-16 |
JP3224814B2 (ja) | 2001-11-05 |
NO925038L (no) | 1993-01-06 |
NZ238804A (en) | 1992-08-26 |
IE912294A1 (en) | 1992-01-15 |
NO925038D0 (no) | 1992-12-30 |
FI930038A (fi) | 1993-01-05 |
DK0538302T3 (da) | 1995-09-18 |
IE74152B1 (en) | 1997-07-02 |
EP0538302B1 (de) | 1995-04-26 |
JPH05508643A (ja) | 1993-12-02 |
PT98177B (pt) | 1998-12-31 |
ATE121627T1 (de) | 1995-05-15 |
PT98177A (pt) | 1993-08-31 |
CA2046014C (en) | 2003-05-20 |
AU641787B2 (en) | 1993-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE121627T1 (de) | Verminderung oder verhütung der von arzneimitteln verursachten hautreizung. | |
WO1992002234A3 (en) | Reduction or prevention of sensitization to drugs | |
ATE429904T1 (de) | Topisch anwendbare arzneipräparate und verfahren zur behandlung | |
ATE292982T1 (de) | Analgesiche synergie durch gleichzeitige verabreichung von subanalgesichen doseneines mu- opioidanagonisten und eines kappa - 2- opioidanagonisten | |
ES2137261T3 (es) | Administracion transdermica de oxibutinina. | |
BR9306841A (pt) | Composição farmacêutica processo para proporcionar um tratamento anti-histamínico o qual não induz qualquer arritmia cardíaca significativa em um paciente ser humano e uso de uma composição para a mnaufactura de um medicamento para uso em um tratamento anti-histamínico | |
WO1994008551A3 (en) | Pharmaceutical compositions and methods for treating cold symptoms | |
ATE262325T1 (de) | Kosmetische, pharmazeutische oder dermatologische zusammensetzung, sowie die zusammensetzung alpha- tnfantagonisten enthaltend | |
KR930702022A (ko) | 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법 | |
ATE515265T1 (de) | Vitamin d und dessen analoge zur behandlung vom tumoren und anderen hyperproliferativen erkrankungen | |
GR3032523T3 (en) | Therapeutic preparation for the transdermal administration of active substances | |
SE9703191D0 (sv) | Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases | |
PT904067E (pt) | Dextrometorfan como agente antitussico administrado transdermicamente | |
ATE77230T1 (de) | Melatoninhaltige mittel sowie deren verwendungen. | |
PT1102586E (pt) | Utilizacao de extractos de ginkgo biloba para a preparacao de um medicamento para o tratamento da esclerose lateral amiotrofica | |
CA2156481A1 (en) | 5-ht2 receptor antagonist compositions useful in treating venous conditions | |
ES2106319T3 (es) | Uso de lactoferrina en la fabricacion de un medicamento para el tratamiento del reumatismo. | |
EP0799618A3 (de) | Verwendung von Alpha-1-Adrenorezeptor-Antagonisten zur Herstellung eines Medikaments für die Vorbeugung und die Behandlung von Krebs | |
BR0311180A (pt) | Métodos para o tratamento de doenças e condições respiratórias utilizando um inibidor seletivo da inos | |
FR2786699B1 (fr) | Medicament destine notamment a prevenir ou traiter les dysfonctions sexuelles | |
GB8923254D0 (en) | Medicaments | |
BR9914792A (pt) | Uso de agentes antifúngicos para tratamento deescleroses | |
NO961180L (no) | Transdermal anordning inneholdende (E)-2-(p-fluorfenetyl)-3-fluorallylamin for behandling av Alzheimers sykdom | |
DE59908258D1 (de) | Blister enthaltend ein transdermales therapeutisches system und eine einzeldosierte darreichungsform | |
RU2002129097A (ru) | Комбинированные терапии с использованием активности, повреждающей сосуды |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |